These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
635 related articles for article (PubMed ID: 32467989)
1. Girdin interaction with vimentin induces EMT and promotes the growth and metastasis of pancreatic ductal adenocarcinoma. Wang W; Chen H; Gao W; Wang S; Wu K; Lu C; Luo X; Li L; Yu C Oncol Rep; 2020 Aug; 44(2):637-649. PubMed ID: 32467989 [TBL] [Abstract][Full Text] [Related]
2. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2. Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of integrin β4 promotes epithelial-mesenchymal transition and is a novel prognostic marker in pancreatic ductal adenocarcinoma. Masugi Y; Yamazaki K; Emoto K; Effendi K; Tsujikawa H; Kitago M; Itano O; Kitagawa Y; Sakamoto M Lab Invest; 2015 Mar; 95(3):308-19. PubMed ID: 25599535 [TBL] [Abstract][Full Text] [Related]
4. Quantitative acetylome and phosphorylome analysis reveals Girdin affects pancreatic cancer progression through regulating Cortactin. Yang L; Fu Q; Miao L; Ding Q; Li X; Wang J; Jiang G; Wang Y Aging (Albany NY); 2020 May; 12(9):7679-7693. PubMed ID: 32369440 [TBL] [Abstract][Full Text] [Related]
5. Girdin regulates the proliferation and apoptosis of pancreatic cancer cells via the PI3K/Akt signalling pathway. Wang S; Lei Y; Cai Z; Ye X; Li L; Luo X; Yu C Oncol Rep; 2018 Aug; 40(2):599-608. PubMed ID: 29901184 [TBL] [Abstract][Full Text] [Related]
6. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells. Lu J; Zhang L; Zhou H; Du Z; Zhang G Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653 [TBL] [Abstract][Full Text] [Related]
7. Anterior gradient 2 downregulation in a subset of pancreatic ductal adenocarcinoma is a prognostic factor indicative of epithelial-mesenchymal transition. Mizuuchi Y; Aishima S; Ohuchida K; Shindo K; Fujino M; Hattori M; Miyazaki T; Mizumoto K; Tanaka M; Oda Y Lab Invest; 2015 Feb; 95(2):193-206. PubMed ID: 25418581 [TBL] [Abstract][Full Text] [Related]
8. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763 [TBL] [Abstract][Full Text] [Related]
9. AREG mediates the epithelial‑mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF‑κB signalling pathway. Wang L; Wang L; Zhang H; Lu J; Zhang Z; Wu H; Liang Z Oncol Rep; 2020 May; 43(5):1558-1568. PubMed ID: 32323797 [TBL] [Abstract][Full Text] [Related]
10. Embigin is overexpressed in pancreatic ductal adenocarcinoma and regulates cell motility through epithelial to mesenchymal transition via the TGF-β pathway. Jung DE; Kim JM; Kim C; Song SY Mol Carcinog; 2016 May; 55(5):633-45. PubMed ID: 25773908 [TBL] [Abstract][Full Text] [Related]
11. CCDC88A, a prognostic factor for human pancreatic cancers, promotes the motility and invasiveness of pancreatic cancer cells. Tanouchi A; Taniuchi K; Furihata M; Naganuma S; Dabanaka K; Kimura M; Watanabe R; Kohsaki T; Shimizu T; Saito M; Hanazaki K; Saibara T J Exp Clin Cancer Res; 2016 Dec; 35(1):190. PubMed ID: 27919290 [TBL] [Abstract][Full Text] [Related]
12. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer. Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160 [TBL] [Abstract][Full Text] [Related]
13. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4. Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191 [TBL] [Abstract][Full Text] [Related]
14. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity. Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945 [TBL] [Abstract][Full Text] [Related]
15. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma. Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067 [TBL] [Abstract][Full Text] [Related]
16. Long non‑coding RNA PCED1B‑AS1 promotes pancreatic ductal adenocarcinoma progression by regulating the miR‑411‑3p/HIF‑1α axis. Zhang Y; Ma H; Chen C Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036383 [TBL] [Abstract][Full Text] [Related]
17. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice. Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868 [TBL] [Abstract][Full Text] [Related]
19. Girdin influences pancreatic cancer progression by regulating c-MYC expression. Shan N; Ni LY; Zhu YS; Shen Y; Gao ZJ; Cai ZZ Neoplasma; 2022 Jan; 69(1):193-202. PubMed ID: 34779642 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma. Li X; Xiao Y; Fan S; Xiao M; Wang X; Zhu X; Chen X; Li C; Zong G; Zhou G; Wan C Hum Pathol; 2016 Nov; 57():182-192. PubMed ID: 27498060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]